Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?

Autores
Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto
Año de publicación
2011
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis.
Fil: Gutiérrez, Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Petiti, Juan Pablo. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: de Paul, Ana Lucia. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Torres, Alicia Ines. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Mukdsi, Jorge Humberto. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina
Materia
RENAL PATHOLOGY
PODOCYTOPATHY
LUPUS
ELECTRON MICROSCOPY
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/241737

id CONICETDig_23c4dc0adf1979799099123be2c37561
oai_identifier_str oai:ri.conicet.gov.ar:11336/241737
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?Gutiérrez, SilvinaPetiti, Juan Pablode Paul, Ana LuciaTorres, Alicia InesMukdsi, Jorge HumbertoRENAL PATHOLOGYPODOCYTOPATHYLUPUSELECTRON MICROSCOPYhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis.Fil: Gutiérrez, Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Petiti, Juan Pablo. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: de Paul, Ana Lucia. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Torres, Alicia Ines. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; ArgentinaFil: Mukdsi, Jorge Humberto. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; ArgentinaSociedad Española de Nefrología Dr Rafael Matesanz2011-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/241737Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto; Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?; Sociedad Española de Nefrología Dr Rafael Matesanz; Nefrología; 32; 2; 11-2011; 246-2470211-6995CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.revistanefrologia.com/es-linkresolver-lupus-related-podocytopathy-could-it-be-X0211699512000843info:eu-repo/semantics/altIdentifier/doi/10.3265/Nefrologia.pre2011.Nov.11138info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:19:52Zoai:ri.conicet.gov.ar:11336/241737instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:19:52.392CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
title Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
spellingShingle Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
Gutiérrez, Silvina
RENAL PATHOLOGY
PODOCYTOPATHY
LUPUS
ELECTRON MICROSCOPY
title_short Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
title_full Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
title_fullStr Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
title_full_unstemmed Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
title_sort Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?
dc.creator.none.fl_str_mv Gutiérrez, Silvina
Petiti, Juan Pablo
de Paul, Ana Lucia
Torres, Alicia Ines
Mukdsi, Jorge Humberto
author Gutiérrez, Silvina
author_facet Gutiérrez, Silvina
Petiti, Juan Pablo
de Paul, Ana Lucia
Torres, Alicia Ines
Mukdsi, Jorge Humberto
author_role author
author2 Petiti, Juan Pablo
de Paul, Ana Lucia
Torres, Alicia Ines
Mukdsi, Jorge Humberto
author2_role author
author
author
author
dc.subject.none.fl_str_mv RENAL PATHOLOGY
PODOCYTOPATHY
LUPUS
ELECTRON MICROSCOPY
topic RENAL PATHOLOGY
PODOCYTOPATHY
LUPUS
ELECTRON MICROSCOPY
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis.
Fil: Gutiérrez, Silvina. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Petiti, Juan Pablo. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: de Paul, Ana Lucia. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Torres, Alicia Ines. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
Fil: Mukdsi, Jorge Humberto. Universidad Nacional de Córdoba. Facultad de Medicina. Centro de Microscopía Electrónica; Argentina
description The classification of lupus nephritis was revised by the ISN/RPS in 2003. The increasingly recognized phenomenon of apparent minimal change disease (MCD) in the context of systemic lupus erythematosus (SLE), is not accepted in the above classification and is associated to a recent new pathological entity called lupus podocitopathy.1 A 32-year-old caucasian woman presented with arthralgia and swelling of the face, hands, and legs. Physical exam revealed pretibial edema and a patch of skin thickening on the left flank, consistent with morphea. Blood presure was 130/70mmHg; proteinuria 4.5g/dl; serum creatinine 0.9mg/dl; and albumin 2g/dl. Urinalysis revealed fat casts. Serology was negative for hepatitis B, C, HIV-1 and HIV-2. ANA titer was 1/1300, C3 70mg/dl and anti ds-DNA was elevated. There was no history of nonsteroidal anti-inflammatory drug use in the patient. A diagnosis of SLE was made. Sections from the needle renal biopsy showed cortex with 10 normocellular glomeruli with mild mesangial hypercellularity and mesangial matrix increased. There were no evident tubular, interstitial, and vascular lesions (Figure 1 A). Immunofluorescence microscopy revealed mesangial granular deposition of IgG (2+) (Figure 1 B), IgA (1+), IgM (1+), C3 (2+) (Figure 1 C) and C1q (3+) (Figure 1D). Ultrastructural analysis showed diffuse effacement (~80%) of the epithelial cell food processes and vacuoles (Figure 2 A). Moreover few electron-dense deposits were noted in mildly expanded mesangium (Figure 2 B). Subepithelial or subendothelial deposits were not observed in the biopsy. Numerous tubulorreticular inclusions within endothelial cells of glomerular capillary were also seen (Figure 2 C). A diagnosis of lupus podocytopathy and lupus nephritis Class I (ISN/RPS) was made. Of particular interest is thepodocyte involvement in different types of lupus glomerulonephritis. For example, patients with non- nephrotic proteinuria and lupus nephritis Class I and II (ISN-RPS) have not revealed significant evidence of effacement of the foot processes. Nevertheless, some adult and children show minimal or proliferative mesangial lupus nephritis and nephrotic proteinuria without peripheral immune complex, exhibiting extensive podocyte effacement, consistent with lupus podocytopathy.1 It is difficult to propose an exact pathogenic mechanism for this lesion given that immune deposits are no detected in glomerular basement membrane, even though it has been hypothesized different mechanisms. Abnormal release of IL-13 from aberrant T cell2, crosstalk between renal dendritic cells and Th cells3 may directly damage to podocytes. Our patient was treated with high-dose prednisone. Six month later she remained normotensive, had no edema, with normal serum creatinine and decreased urinary protein excretion (0,5g/d). In agreement with this result Kraft et al1 have shown a significant reduction in proteinuria at last follow-up. Therefore, the podocytopathy in the SLE context responded to oral corticosteroids, remarking the important therapeutic implications of the diagnosis of this particular entity. In summary, lupus podocytopathy has become an intersting point both clinical discussion and futures investigations about the role of podocyte and it should be added to the classification of lupus nephritis.
publishDate 2011
dc.date.none.fl_str_mv 2011-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/241737
Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto; Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?; Sociedad Española de Nefrología Dr Rafael Matesanz; Nefrología; 32; 2; 11-2011; 246-247
0211-6995
CONICET Digital
CONICET
url http://hdl.handle.net/11336/241737
identifier_str_mv Gutiérrez, Silvina; Petiti, Juan Pablo; de Paul, Ana Lucia; Torres, Alicia Ines; Mukdsi, Jorge Humberto; Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?; Sociedad Española de Nefrología Dr Rafael Matesanz; Nefrología; 32; 2; 11-2011; 246-247
0211-6995
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.revistanefrologia.com/es-linkresolver-lupus-related-podocytopathy-could-it-be-X0211699512000843
info:eu-repo/semantics/altIdentifier/doi/10.3265/Nefrologia.pre2011.Nov.11138
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Sociedad Española de Nefrología Dr Rafael Matesanz
publisher.none.fl_str_mv Sociedad Española de Nefrología Dr Rafael Matesanz
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846083347504168960
score 13.22299